Herbert Loong: As an oncologist from Hong Kong, it’s a tremendous honour for me to take up this role
Herbert Loong shared a post on LinkedIn:
“With the close of ASCO24 tomorrow, I want to thank friends and colleagues of the global oncology community for your support as I assume the Chair of American Society of Clinical Oncology (ASCO) International Affairs Committee.
As an oncologist from Hong Kong, it’s a tremendous honour for me to take up this role.
Lots to learn in the coming year!”
Source: Herbert Loong/LinkedIn
Herbert Loong is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK), with additional roles as Deputy Medical Director of the Phase 1 Clinical Trials Centre and founder of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.
Dr. Loong has co-founded key organizations like the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC). His involvement in international oncology bodies, including ASCO and IASLC, underscores his commitment to advancing cancer research and treatment on a global scale.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023